Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Sexually Transmitted Diseases

Free Subscription Articles published in J Natl Cancer Inst Retrieve available abstracts of 21 articles: HTML format

Single Articles

July 2024
1. TRAKIMAS DR, Mydlarz W, Mady LJ, Koch W, et al
   Increasing radiation therapy and lower survival for human papillomavirus-related oropharynx cancer associated with a shift to community cancer center care.
   J Natl Cancer Inst. 2024;116:1051-1062.
   PubMed     Abstract available
   
   
   March 2024
2. ARBYN M, Rousta P, Bruni L, Schollin Ask L, et al
   Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer.
   J Natl Cancer Inst. 2024 Mar 19:djae042. doi: 10.1093.
   PubMed    
   
   
   
3. GOPALANI SV, Saraiya M, Huang B, Tucker TC, et al
   Population-level incidence of HPV-positive oropharyngeal, cervical, and anal cancers by smoking status.
   J Natl Cancer Inst. 2024 Mar 1:djae054. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2024
4. GOPALANI SV, Senkomago V, Rim SH, Saraiya M, et al
   Human papillomavirus-associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates-United States, 2001-2019.
   J Natl Cancer Inst. 2024;116:275-282.
   PubMed     Abstract available
   
   
   January 2024
5. PALMER TJ, Kavanagh K, Cuschieri K, Cameron R, et al
   Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation.
   J Natl Cancer Inst. 2024 Jan 22:djad263. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2023
6. BAANDRUP L, Maltesen T, Dehlendorff C, Kjaer SK, et al
   HPV vaccination and anal high-grade precancerous lesions and cancer: a real-world effectiveness study.
   J Natl Cancer Inst. 2023 Sep 18:djad189. doi: 10.1093.
   PubMed     Abstract available
   
   
   July 2023
7. GRADISSIMO A, Clarke MA, Xue X, Castle PE, et al
   A Novel HPV/Host DNA Methylation-Score and Detection of Cervical Adenocarcinoma.
   J Natl Cancer Inst. 2023 Jul 19:djad134. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. BEFANO B, Campos NG, Egemen D, Herrero R, et al
   Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial.
   J Natl Cancer Inst. 2023;115:788-795.
   PubMed     Abstract available
   
   
   April 2023
9. CASTLE PE
   Prophylactic human papillomavirus vaccination for prevention of oropharyngeal cancer in older men: is the juice worth the squeeze?
   J Natl Cancer Inst. 2023;115:349-351.
   PubMed    
   
   
   January 2023
10. LANDY R, Haber G, Graubard BI, Campos NG, et al
    Upper age-limits for US male HPV-vaccination for oropharyngeal cancer prevention: A microsimulation-based modeling study.
    J Natl Cancer Inst. 2023 Jan 19:djad009. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2022
11. KREIMER AR, Cernuschi T, Rees H, Brotherton JML, et al
    Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule.
    J Natl Cancer Inst. 2022 Oct 4. pii: 6747964. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2022
12. HU SY, Kreimer AR, Porras C, Guillen D, et al
    Performance of cervical screening a decade following HPV vaccination: The Costa Rica Vaccine Trial.
    J Natl Cancer Inst. 2022 May 31. pii: 6596052. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. LALONDE CS, Teng Y, Burtness BA, Ferris RL, et al
    The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss.
    J Natl Cancer Inst. 2022 May 14. pii: 6585900. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2022
14. HUEPENBECKER SP, Meyer LA
    How Can We Pursue Equity in Cervical Cancer Prevention with Existing HPV Genotype Differences?
    J Natl Cancer Inst. 2022 Feb 17. pii: 6530293. doi: 10.1093.
    PubMed    
    
    
    
15. MIX J, Saraiya M, Hallowell BD, Befano B, et al
    Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management.
    J Natl Cancer Inst. 2022 Feb 17. pii: 6530292. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2021
16. CORREDOR G, Toro P, Koyuncu C, Lu C, et al
    An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients with HPV-Associated Oropharyngeal Cancer.
    J Natl Cancer Inst. 2021 Nov 29. pii: 6446037. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2021
17. DEHLENDORFF C, Baandrup L, Kjaer SK
    Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers.
    J Natl Cancer Inst. 2021;113:869-874.
    PubMed     Abstract available
    
    
    June 2021
18. BURTNESS B, Contessa J
    Hypoxia-Guided Therapy for Human Papillomavirus-Associated Oropharynx Cancer.
    J Natl Cancer Inst. 2021;113:652-653.
    PubMed    
    
    
    
19. DESHMUKH AA, Suk R, Shiels MS, Damgacioglu H, et al
    Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017.
    J Natl Cancer Inst. 2021;113:792-796.
    PubMed     Abstract available
    
    
    April 2021
20. CAMPOS NG, Chaturvedi AK, Kreimer AR
    Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies.
    J Natl Cancer Inst. 2021 Apr 20. pii: 6227604. doi: 10.1093.
    PubMed    
    
    
    
21. KJAER SK, Dehlendorff C, Belmonte F, Baandrup L, et al
    Real-world Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
    J Natl Cancer Inst. 2021 Apr 20. pii: 6227603. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge.